Bionano study finds genome mapping detects 97.8% of T-cell leukemia cases
Go back to Bionano study finds genome mapping detects 97.8% of T-cell leukemia cases| (NASDAQ: BNGO) | Delayed: 1.15 +0.01 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.14 | 52 Week High | $ | |||
| Open | $1.14 | 52 Week Low | $ | |||
| Day High | $1.17 | P/E | N/A | |||
| Day Low | $1.14 | EPS | $ | |||
| Volume | 68,808 | |||||
